InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,220.99
(
-0.03%
)
US TECH 100
17,717.20
(
0.20%
)
Dow Jones
39,456.38
(
-0.14%
)
Brent Oil
83.27
(
1.07%
)
Bitcoin
63,045.38
(
2.60%
)
Post# of 40492
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DeepDive

Send PM Follow Ignore
Followers 20
Posts 456
Boards Moderated 0
Alias Born 10/27/2012

DeepDive

Re: radly post# 13812

Tuesday, 02/28/2017 2:34:48 PM

Tuesday, February 28, 2017 2:34:48 PM

Post# of 40492
Before a serious phase 2, a drug will not generate serious value. Add in the lack of credibility of people that never brought a drug to market in this corp. + pumping by people like Agora and you get no interest from serious players. This might change if they cross P.2 with similar results.

Long.

Ad
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent INO News
More INO News
InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news
Only $200 per official company press release!